235 related articles for article (PubMed ID: 30321645)
21. The association between human leukocyte antigen eplet mismatches, de novo donor-specific antibodies, and the risk of acute rejection in pediatric kidney transplant recipients.
Sharma A; Taverniti A; Graf N; Teixeira-Pinto A; Lewis JR; Lim WH; Alexander SI; Durkan A; Craig JC; Wong G
Pediatr Nephrol; 2020 Jun; 35(6):1061-1068. PubMed ID: 32065279
[TBL] [Abstract][Full Text] [Related]
22. Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development.
Wiebe C; Rush DN; Nevins TE; Birk PE; Blydt-Hansen T; Gibson IW; Goldberg A; Ho J; Karpinski M; Pochinco D; Sharma A; Storsley L; Matas AJ; Nickerson PW
J Am Soc Nephrol; 2017 Nov; 28(11):3353-3362. PubMed ID: 28729289
[TBL] [Abstract][Full Text] [Related]
23. The Accuracy of Sequence-Specific Oligonucleotide and Real-Time Polymerase Chain Reaction HLA Typing in Determining the Presence of Pre-Transplant Donor-Specific Anti-HLA Antibodies and Total Eplet Mismatches for Deceased Donor Kidney Transplantation.
Larkins NG; D'Orsogna L; Taverniti A; Sharma A; Chakera A; Chan D; Krishnan A; Wong G; Lim WH
Front Immunol; 2022; 13():844438. PubMed ID: 35799779
[TBL] [Abstract][Full Text] [Related]
24. Immunologic risk stratification of pediatric heart transplant patients by combining HLAMatchmaker and PIRCHE-II.
Mangiola M; Ellison MA; Marrari M; Bentlejewski C; Sadowski J; Zern D; Niemann M; Feingold B; Webber SA; Zeevi A;
J Heart Lung Transplant; 2022 Jul; 41(7):952-960. PubMed ID: 35437211
[TBL] [Abstract][Full Text] [Related]
25. Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation.
Yanyiam P; Kantachuvesiri S; Thammanichanond D
Transplant Proc; 2024 Apr; 56(3):515-520. PubMed ID: 38368130
[TBL] [Abstract][Full Text] [Related]
26. Eplet matching in pediatric heart transplantation: The SickKids experience.
Cardoso B; Wang J; Kiernan J; Dipchand AI
J Heart Lung Transplant; 2022 Oct; 41(10):1470-1477. PubMed ID: 35933296
[TBL] [Abstract][Full Text] [Related]
27. HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients.
Sullivan PM; Warner P; Kemna MS; Albers EL; Law SP; Weiss NS; Law YM
J Heart Lung Transplant; 2015 Jul; 34(7):950-7. PubMed ID: 25727771
[TBL] [Abstract][Full Text] [Related]
28. Urinary CXCL10 specifically relates to HLA-DQ eplet mismatch load in kidney transplant recipients.
San Segundo D; Guiral-Foz SA; Benito-Hernández A; Fernández AR; Arnau A; Valero R; Ramos-Barrón MA; García-Unzueta MT; Gómez-Ortega JM; López-Hoyos M; Ruiz JC; Rodrigo E
Transpl Immunol; 2022 Feb; 70():101494. PubMed ID: 34774739
[TBL] [Abstract][Full Text] [Related]
29. Donor Specific Antibodies are not only directed against HLA-DR: Minding your Ps and Qs.
Cross AR; Lion J; Loiseau P; Charron D; Taupin JL; Glotz D; Mooney N
Hum Immunol; 2016 Nov; 77(11):1092-1100. PubMed ID: 27060781
[TBL] [Abstract][Full Text] [Related]
30. Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation.
Meneghini M; Crespo E; Niemann M; Torija A; Lloberas N; Pernin V; Fontova P; Melilli E; Favà A; Montero N; Manonelles A; Cruzado JM; Palou E; Martorell J; Grinyó JM; Bestard O
Front Immunol; 2020; 11():623276. PubMed ID: 33776988
[TBL] [Abstract][Full Text] [Related]
31. Terasaki Epitope Mismatch Burden Predicts the Development of De Novo DQ Donor-Specific Antibodies and are Associated With Adverse Allograft Outcomes.
Willicombe M; Blow M; Santos-Nunez E; Freeman C; Brookes P; Taube D
Transplantation; 2018 Jan; 102(1):127-134. PubMed ID: 28731902
[TBL] [Abstract][Full Text] [Related]
32. De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy.
Willicombe M; Brookes P; Sergeant R; Santos-Nunez E; Steggar C; Galliford J; McLean A; Cook TH; Cairns T; Roufosse C; Taube D
Transplantation; 2012 Jul; 94(2):172-7. PubMed ID: 22735711
[TBL] [Abstract][Full Text] [Related]
33. Eplet incompatibility in pediatric renal transplantation.
Rãchişan AL; Dubois V; Ranchin B; Sellier-Leclerc AL; Bertholet Thomas A; Cochat P; Bacchetta J
Pediatr Transplant; 2020 Sep; 24(6):e13721. PubMed ID: 32388894
[TBL] [Abstract][Full Text] [Related]
34. Mismatch epitope load predicts de novo-DSA-free survival in pediatric liver transplantation.
Shin S; Lee M; Dente E; Yazigi N; Khan KM; Kaufman SS; Ahn J; Timofeeva OA; Ekong UD
Pediatr Transplant; 2022 Jun; 26(4):e14251. PubMed ID: 35279919
[TBL] [Abstract][Full Text] [Related]
35. HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapy.
Bezstarosti S; Meziyerh S; Reinders MEJ; Voogt-Bakker K; Groeneweg KE; Roelen DL; Kers J; de Fijter JW; Heidt S
HLA; 2023 Jul; 102(1):3-12. PubMed ID: 36841928
[TBL] [Abstract][Full Text] [Related]
36. Repeated human leukocyte antigen mismatches in lung re-transplantation.
Sommer W; Hallensleben M; Ius F; Kühn C; Tudorache I; Avsar M; Salman J; Siemeni T; Greer M; Gottlieb J; Boethig D; Blasczyk R; Haverich A; Warnecke G
Transpl Immunol; 2017 Feb; 40():1-7. PubMed ID: 27923603
[TBL] [Abstract][Full Text] [Related]
37. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
[TBL] [Abstract][Full Text] [Related]
38. Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients.
Lee H; Min JW; Kang H; Lee H; Eum SH; Park Y; Yang CW; Chung BH; Oh EJ
Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806362
[TBL] [Abstract][Full Text] [Related]
39. hlaR: A rapid and reproducible tool to identify eplet mismatches between transplant donors and recipients.
Johnson AC; Zhang J; Cliff Sullivan H; Wiebe C; Bray R; Gebel H; Larsen CP
Hum Immunol; 2022 Mar; 83(3):248-255. PubMed ID: 35101308
[TBL] [Abstract][Full Text] [Related]
40. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
Almeshari K; Pall A; Chaballout A; Elgamal H; Almana H; Alzayer F; Abaalkhail N; Altalhi M
Clin Transpl; 2011; ():395-400. PubMed ID: 22755437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
